The anti-inflammatory drug phenylbutazone has been found to inhibit both engulfment and intracellular killing of E. coli by guinea pig peritoneal polymorphonuclear (PMN) leukocytes. The bactericidal activity of leukocytic homogenates was also inhibited by the drug. Addition of the drug at various time intervals to a phagocytic reacting system caused an almost immediate cessation of bactericidal activity. Metabolic studies showed that the drug sharply curtailed glucose-1-'4C and '4C-formate oxidation of both resting and phagocytizing PMN leukocytes. These data indicated an effect upon the hexose monophosphate shunt and H202 formation. Further investigation showed that the sites of inhibition were on glucose-6-phosphate and 6-phosphogluconate dehydrogenase. These inhibitions resulted in decreased H202 production. It is suggested that H202 activates lysosomes and subsequently complexes with the lysosomal enzyme, myeloperoxidase. This complex is a potent bactericidal agent in the phagocyte.
The anti-inflammatory drug phenylbutazone has been found to inhibit both engulfment and intracellular killing of E. coli by guinea pig peritoneal polymorphonuclear (PMN) leukocytes. The bactericidal activity of leukocytic homogenates was also inhibited by the drug. Addition of the drug at various time intervals to a phagocytic reacting system caused an almost immediate cessation of bactericidal activity. Metabolic studies showed that the drug sharply curtailed glucose-1-'4C and '4C-formate oxidation of both resting and phagocytizing PMN leukocytes. These data indicated an effect upon the hexose monophosphate shunt and H202 formation. Further investigation showed that the sites of inhibition were on glucose-6-phosphate and 6-phosphogluconate dehydrogenase. These inhibitions resulted in decreased H202 production. It is suggested that H202 activates lysosomes and subsequently complexes with the lysosomal enzyme, myeloperoxidase. This complex is a potent bactericidal agent in the phagocyte.
Phagocytosis and intracellular killing of bacteria are important physiological functions of polymorphonuclear (PMN) leukocytes. These functions are mediated through a variety of glycolytic and oxidative metabolic events. The observation that glycolytic inhibitors such as iodoacetate and fluoride inhibit phagocytosis, whereas respiratory inhibitors such as cyanide and antimycin A do not, indicates that the energy required for engulfment must come from glycolysis (13) . A number of oxidative metabolic activities which accompany phagocytosis have also been described. Recently, we attempted to identify those metabolic activities involved with entry and those associated with intracellular killing. Changes in glycolytic events were found to be related to actual engulfment, whereas changes in oxidative events were found to be associated with intracellular killing (16) .
Stimulation of oxygen consumption, increased flow of glucose through the hexose monophosphate shunt (HMS), and increased formation of H202 (3) are all oxidative events which are intimately involved with the bactericidal activity of the phagocyte. Anaerobically, these reactions would be expected to function minimally and bactericidal activity should be reduced. It has been shown in our laboratory that the bactericidal activity of phagocytes incubated anaerobically is significantly reduced when compared with the bactericidal activity of phagocytes incubated aerobically (8, 16) .
Earlier reports have shown that a major portion of the bactericidal activity of the PMN is due to a complex of H202 and the lysosomal enzyme, myeloperoxidase (6, 19) . The H202 is an end product of the oxidation of reduced nicotinamide adenine dinucleotide phosphate (NADPH) which arises from the HMS (4). The increase in the HMS is believed to be due to the recycling of NADP+ (12) , the cofactor for glucose-6-phosphate dehydrogenase (G6PDH) and 6-phosphogluconate dehydrogenase (6PGDH), two key enzymes of this pathway. The increased intracellular H202 formed from the NADPH oxidase reaction is thought to result in lysosomal changes which cause the release of, among many enzymes, myeloperoxidase. In addition, it has recently been shown that halides, especially the iodide ion, further increase the activity of this system (5) .
Phenylbutazone, a clinically useful antiinflammatory agent, inhibits the release of lysosomal enzymes (18 Phagocytic and bactericidal activities of PMN were carried out essentially as previously described (7) . Briefly, phagocytosis was determined by light microscopy. Bactericidal activity was determined by plate counts of viable organisms at time zero and several time intervals thereafter. The change in colony count from time zero onward was used as a measure of bactericidal activity.
Cell homogenates to be tested for bactericidal activity were prepared from guinea pig PMN leukocytes by homogenizing the cells for 5 min in ice-cold 0.25 M sucrose solution in a motor-driven PotterElvehjem homogenizer with a Teflon pestle. Homogenates for enzyme studies were prepared in ice-cold KRPM at pH 7.4. Homogenization, in the same apparatus, was carried out for 2 min. This time interval was found to be sufficient for extraction of optimal enzyme activity. G6PDH and 6PGDH assays were done on the supernatant fluids obtained from homogenates centrifuged at 14,000 X g for 30 min in a Sorvall RC III centrifuge.
G6PDH and 6PGDH were assayed spectrophotometrically at 340 nm in a Beckman DB spectrophotometer with 1-cm borosilicate glass cuvettes. The reaction mixtures consisted of 0.1 ml of extract for G6PDH and 0.3 ml for 6PGDH, 5 ,umoles of sub- (13) . Glucose-1-14C oxidation and 14C-formate oxidation were measured by trapping radioactive CO2 as barium carbonate. Planchettes were prepared and counted as previously described (15) . Formate oxidation was employed for measurement of H202 production, since the drug interfered with the more direct fluorometric method of assay. These procedures have been previously described in detail (11) .
All chemicals used in these studies were of reagent grade and were purchased from commercial sources. Radiochemicals were obtained from the New England Nuclear Corp., Boston, Mass. Phenylbutazone was a gift from the Geigy Pharmaceutical Co., Ardsley, N.Y.
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RESULTS
The effect of phenylbutazone on the bactericidal properties of guinea pig peritoneal PMN is shown in Fig. 1 . The drug was able to inhibit the killing of E. coli by leukocytes, and this effect was related to its concentration. The minimal effective concentration was between 2.5 and 5.0 ,umoles per ml. These concentrations of phenylbutazone were not found to be toxic to the PMN as judged by neutral red dye uptake. Examination by light microscopy revealed that the same concentrations also inhibited uptake of bacteria. The degree of inhibition was approximately 50%.-To ascertain whether this inhibition of bactericidal activity by phenylbutazone was due only to an inhibition of bacterial uptake by the phagocyte or to some other mechanism, the effect of the drug on the bactericidal activity of PMN homogenates was studied (Fig. 2) . Phenylbutazone at 5 Amoles/ml curtailed the bactericidal activity of PMN homogenates almost to the same extent as that of the intact cells. In addition, phenylbutazone was added to the phagocytic mixture at various time intervals after the leukocytes were exposed to E. coli. The time intervals used were 0, 5, 10, and 13 min after the addition of bacteria. The results of this experiment (Fig. 3) indicate that, even though the phagocytes were in the process of killing bacteria, addition of the drug immediately inhibited further significant bactericidal activity. Additional evidence that the drug affects the intracellular bactericidal activity of the phagocyte was shown by another experiment; in this experiment, phenylbutazone was added to PMN leukocytes which had been allowed to phagocytize E. coli for a 5-min period in the absence of the drug and had subsequently been washed free from all but engulfed or associated organisms. After a 30-min incubation period, an 85% reduction in bacterial viability was noted. In the presence of the drug, added after the "wash-out" of extracellular bacteria, no reduction in bacterial numbers was observed.
To determine the possible site of action of the drug, its effect on certain metabolic parameters was measured. Phenylbutazone at 5 and "4C-formate oxidation in both resting and phagocytizing guinea pig PMN leukocytes (Table 1 ).
The effect of phenylbutazone on G6PDH, the first enzyme of the HMS, is shown in Fig. 4 . These data show that 5 ,umoles of the drug per ml was sufficient for 83% inhibition of the enzyme. Higher concentrations of the antiinflammatory agent caused almost complete inhibition of activity. Figure 5 shows the effect of the same concentration of phenylbutazone on 6PGDH. This enzyme was inhibited by 67% in terms of specific activity. Hence, 5 ,umoles of phenylbutazone per ml, a concentration which effectively inhibited the bactericidal activity of guinea pig peritoneal PMN, was inhibitory to the first two enzymes of the HMS.
As indicated above, this drug inhibited formate oxidation, a reaction used to measure indirectly cellular H202 production (3). H202 is thought to be generated by the action of NADPH oxidase on the reduced coenzyme. The effect of phenylbutazone on this oxidase was examined and the results are presented in Table 2 . Phenylbutazone caused an increase in oxygen consumption and a decrease in lactate formation. The presence of the reduced cofactor in the absence of the drug caused an increase in oxygen consumption and no change in lactate formation. The drug had no apparent effect on oxygen consumption in the presence of NADPH, but lactic acid production was reduced.
DIscussIoN
Phenylbutazone inhibited both uptake and intracellular killing of E. coli by guinea pig peritoneal PMN. Since both parameters were inhibited, the question arose as to whether the inhibition of bactericidal activity was dependent upon the inhibition of bacterial engulfment. This question was resolved by testing the effect of the drug on the bactericidal property of PMN homogenates. We have previously shown that PMN homogenates are bactericidal (A. Mukherjee et al., in press). This system does not require engulfment of bacteria as a prerequisite for bactericidal activity and is not limited by any permeability problem which might exist in a whole cell system. These experiments revealed VOL. 96, 1968 These data suggest that phenylbutazone inhibits both particle uptake and bactericidal activity. Furthermore, these two events appear to be independent of one another.
At this point, it seemed appropriate to explore the possible mechanism of action of phenylbutazone upon bacterial uptake and intracellular killing by PMN. Since it is already well known (13, 16) that the act of engulfment of particulate material, including bacteria, is an energy-requiring process, and that this energy is obtained via glycolysis (16), we next determined the effect of phenylbutazone on glycolysis. As shown in Table  2 , the drug inhibited homogenate glycolysis as indicated by a decrease in lactic acid formation. The result of this inhibition would be to limit adenosine triphosphate formation and therefore limit the amount of energy available for particle entry.
The bactericidal activity of phagocytes is associated with an increased flow of glucose through the HMS (13) . To ascertain the activity of phenylbutazone on the HMS, we determined its effect on the oxidation of glucose-1_14C by resting and phagocytizing PMN. These experiments showed that phenylbutazone markedly inhibited glucose-1-14C oxidation by both resting and stimulated phagocytes. Indeed, the marked increase in this activity resulting from phagocytosis was completely abolished by the drug and was, in fact, decreased to the same level as that of the drug-treated resting cells.
Previously, we suggested that a function of the stimulated HMS in phagocytizing cells is to make available a greater quantity of H202 (11) . H202 has been reported to be a major component of the bactericidal system in the PMN (6, 8) . Since the HMS was inhibited by phenylbutazone, it would be expected that H202 formation would be similarly affected. Phenylbutazone markedly inhibited H202 formation, as indicated by formate oxidation, by both resting and phagocytizing PMN.
Further experiments designed to localize more precisely the site of action of the drug showed that G6PDH and 6PGDH, two key enzymes of the HMS which require NADP+ as a cofactor, were significantly inhibited by 5 ,umoles of phenylbutazone per ml. The apparent lack of a significant effect of the drug on NADPH oxidation by PMN homogenates suggests that the inhibitory effect is probably not on the oxidase reaction. It is interesting to note that the addition of NADPH to the homogenates stimulated the respiratory activity without increasing lactic acid production. These findings will be discussed in a subsequent report.
The inhibition of glycolysis by phenylbutazone is probably due to the inhibition of G6PDH and 6PGDH. The inhibition of these enzymes would result in an increase in intracellular glucose-6-phosphate (G6P). Accumulation of this intermediate inhibits hexokinase (9) , and the result would be curtailment of glycolytic activity. It has been reported that phenylbutazone uncouples oxidative phosphorylation (20) and that 2, 4-dinitrophenol, also an uncoupler of oxidative phosphorylation, does not affect particle entry or intracellular killing (10, 13) . The ability of phenylbutazone to inhibit both glycolytic and HMS activity in the phagocyte provides a plausible explanation for the differences noted in the mode of action of these two agents.
The observation of Weissmann (18) that phenylbutazone inhibited the release of lysosomal enzymes in vivo but had no effect on lysosomes in vitro may be indicative of an indirect action of the drug on these intracellular granules. H202 has been shown to be a lysosomal labilizing agent (19) . The inhibition of H202 production noted in this study may prevent lysosomal degradation. Accumulation of H202 rather than lactate may be a prime stimulus for lysosomal breakdown, since Holmes et al. (2) found that leukocytes from patients with chronic granulomatous disease showed increased lactate production during phagocytosis without showing increased degranulation, as would be expected if lactic acid were directly involved with the degranulation process. Also, Nakae et al. (10) showed that oxamic acid, which significantly reduced lactate formation by macrophages, did not similarly affect the bactericidal activity of phagocytes. A previous report (8) showed that H202 and myeloperoxidase act synergistically as a potent bactericidal agent. Thus, a decrease in H202 production in the cell may also result in decreased availability of myeloperoxidase. This would, in effect, remove at least two major components of the bactericidal system of the phagocyte. As mentioned previously, halides have also been reported to be involved in killing (5) . In this study, the halide content of the suspending fluids would fulfill this requirement (6) . Zeya and Spitznagel (21) , Skarnes (17), and press) during phagocytosis is the common denominator necessary for "activating" intracellular killing of the myriad of bacteria to which the phagocyte is exposed.
On the basis of our experiments, the usual clinical dosage of phenylbutazone should not enhance susceptibility to infection in man. To attain a blood level in man equal to our minimal effective in vitro concentration, the dose would have to be greater than 10 g, which is far in excess of that recommended for treatment of inflammatory disease. Studies on the effect of the drug in animals are in progress and will be the subject of another report.
